Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",26960,100,1.00 [0.80-1.26],0.9679636800598724
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27517,143,1.08 [0.90-1.30],0.3990112029184572
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27266,972,1.09 [1.02-1.18],0.0129269474046377
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Candidiasis,27547,297,1.14 [1.00-1.29],0.0512369097665575
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26772,2704,1.06 [1.02-1.11],0.0056405078247025
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27018,2040,1.05 [1.00-1.10],0.0733986202410597
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27342,983,1.09 [1.01-1.17],0.0201007208901566
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,27465,45,0.78 [0.54-1.11],0.1659968279879898
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26305,625,1.08 [0.99-1.18],0.0772394639528397
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25440,601,1.10 [1.00-1.20],0.0402274838571243
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,25677,166,1.13 [0.95-1.34],0.1724840281728148
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,20536,1185,1.09 [1.02-1.17],0.0073637833779569
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,25446,276,1.13 [0.99-1.29],0.0800023241829686
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27501,1142,1.08 [1.01-1.15],0.0246294620964031
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Mycoses,27606,356,1.09 [0.97-1.22],0.1619366921500191
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26882,588,1.14 [1.04-1.25],0.0042555428345577
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27549,689,1.06 [0.98-1.16],0.1631839960230404
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26503,144,1.07 [0.89-1.29],0.4534075804075319
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,27646,33,1.18 [0.81-1.73],0.3793599998641652
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27465,605,1.06 [0.97-1.16],0.2197777158293269
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27490,70,1.16 [0.89-1.50],0.2762712801576831
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27553,168,1.15 [0.97-1.36],0.1047611083535909
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27538,153,1.14 [0.95-1.36],0.151323729419055
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26622,328,1.19 [1.06-1.34],0.0034421859303701
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,26527,233,1.01 [0.87-1.17],0.8776460182504623
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,26437,78,1.02 [0.79-1.31],0.8882272005757434
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,27617,54,0.87 [0.64-1.20],0.4084695694895519
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27584,127,0.92 [0.75-1.13],0.4132588398866124
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral warts,27501,44,0.70 [0.48-1.01],0.0591441945296705
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],27506,49,1.07 [0.78-1.48],0.673139702966981
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm,27359,315,1.07 [0.94-1.21],0.2839793707482296
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27555,75,1.18 [0.92-1.52],0.1893522323715424
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27536,79,1.22 [0.95-1.55],0.1134879383281005
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,12319,44,0.94 [0.66-1.33],0.7261091828082182
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27453,1174,1.01 [0.94-1.08],0.7824243228933869
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of meninges,27634,46,1.34 [0.98-1.84],0.0646131927821266
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27611,49,1.06 [0.77-1.45],0.7252291068572898
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,27624,87,1.11 [0.88-1.41],0.3789437031087334
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of ovary,15267,98,0.97 [0.77-1.22],0.7739968575098436
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Ascending colon,27639,270,0.98 [0.86-1.13],0.8279841290802771
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Caecum,27635,205,0.99 [0.85-1.17],0.9475639751160008
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27578,57,0.92 [0.68-1.25],0.5938953870245118
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Descending colon,27638,173,0.93 [0.78-1.11],0.4146096159235103
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Rectum,27602,288,0.99 [0.87-1.14],0.933576044660909
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27572,539,0.97 [0.88-1.07],0.5755723356537822
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Transverse colon,27639,309,1.02 [0.90-1.16],0.776577584446209
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Carcinoma in situ of breast,13139,87,0.68 [0.52-0.89],0.0045483960910418
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",13187,100,0.85 [0.67-1.08],0.188009111585831
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",23902,31,0.83 [0.54-1.27],0.3829261119788701
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",23908,37,0.94 [0.64-1.38],0.7705613704973922
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27606,109,1.11 [0.90-1.37],0.3452611417542799
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Haemangioma, any site",27606,107,1.11 [0.90-1.37],0.3417657341057307
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Leiomyoma of uterus,14633,414,0.95 [0.85-1.07],0.4046387539159854
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Lung cancer and mesothelioma,20569,176,1.19 [1.01-1.40],0.0386765745772499
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Lymphoid leukaemia,23900,29,1.04 [0.68-1.58],0.8592419516500305
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24018,147,1.06 [0.88-1.27],0.5555399902186107
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",23956,85,1.12 [0.88-1.43],0.338944287723428
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",13241,84,1.00 [0.78-1.28],0.9847321975493906
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",23922,51,0.93 [0.68-1.29],0.6822980227016443
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",23934,63,1.07 [0.81-1.43],0.6233181952216691
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",23940,69,1.04 [0.79-1.36],0.7795259719347766
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",13210,53,1.15 [0.85-1.55],0.375862659698461
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",23927,56,1.15 [0.86-1.54],0.3399177357165611
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11123,409,1.03 [0.92-1.15],0.6390203782112122
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",23957,86,1.04 [0.81-1.33],0.7531373887004909
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",23925,54,1.17 [0.87-1.58],0.3028501716639681
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,23935,64,0.96 [0.72-1.28],0.7879144520883347
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanocytic naevi,27407,212,0.96 [0.82-1.13],0.6394422602534384
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanocytic naevi of trunk,27597,93,0.92 [0.72-1.16],0.4738345707279084
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanoma in situ,23885,50,1.22 [0.89-1.66],0.2117595083767631
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",23929,58,0.87 [0.64-1.19],0.3891589047139715
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",23987,116,1.00 [0.81-1.23],0.9899951453804968
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",23993,122,1.21 [0.99-1.48],0.0636164295768805
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",23939,68,1.14 [0.87-1.49],0.3369525942219941
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Other benign neoplasms of skin,27463,135,0.99 [0.82-1.21],0.9319829097560868
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",24512,641,0.97 [0.88-1.06],0.4559581687956312
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24542,671,0.98 [0.89-1.07],0.599841722185312
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27379,280,0.99 [0.87-1.14],0.9132550752618792
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,26240,57,1.03 [0.76-1.38],0.8703406223699436
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27167,68,1.24 [0.95-1.60],0.1077750551975921
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26851,2216,1.05 [1.00-1.10],0.0461900239513161
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,26462,24,0.90 [0.56-1.44],0.6487675846281539
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27296,36,1.07 [0.74-1.55],0.702462449785241
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27202,1019,1.10 [1.03-1.18],0.0066249178136982
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27202,1019,1.10 [1.03-1.18],0.0066249178136982
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,26240,57,1.15 [0.86-1.54],0.3542321757645414
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27362,924,1.08 [1.00-1.16],0.0430054620681636
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,27373,113,0.94 [0.76-1.17],0.5874312462806472
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27152,53,1.32 [0.99-1.76],0.0580843268975525
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27142,43,1.11 [0.80-1.56],0.5292994977647232
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,27450,190,0.87 [0.73-1.03],0.0976647295436901
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27568,69,1.11 [0.85-1.45],0.4305934432085687
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",27418,158,0.78 [0.65-0.95],0.0118410374494053
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,26513,75,0.94 [0.72-1.23],0.652201469950068
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,23760,208,1.02 [0.88-1.20],0.7604138385528474
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,25720,128,1.08 [0.88-1.31],0.4633368356553647
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,25728,136,1.25 [1.03-1.50],0.0202915114543518
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,23590,38,1.52 [1.10-2.11],0.0109969403919784
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,25670,70,0.96 [0.73-1.26],0.7702753051069984
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25337,150,1.13 [0.95-1.36],0.1646695274861243
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",27500,165,1.05 [0.89-1.25],0.5510363928815294
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,27380,45,0.92 [0.65-1.30],0.643740546753548
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,27371,36,1.06 [0.73-1.54],0.7549253917349527
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27237,1637,1.04 [0.99-1.10],0.1320342307316721
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,24753,1587,1.05 [1.00-1.12],0.0669270736672959
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",23592,40,1.19 [0.84-1.68],0.3228479539178417
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",25968,58,0.90 [0.67-1.23],0.5164851880942778
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,23738,186,1.34 [1.15-1.56],0.0001593454615398
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,23616,64,1.44 [1.11-1.86],0.0053581789401821
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,25937,2385,1.14 [1.09-1.19],1.0550835308506289e-08
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,23670,118,1.11 [0.91-1.36],0.2946137192791969
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,23939,387,1.22 [1.10-1.36],0.0002637145221007
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27545,269,1.17 [1.03-1.34],0.018448967154165
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,27384,108,1.15 [0.93-1.42],0.2041753603202477
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,23650,98,1.13 [0.90-1.40],0.2886506709708515
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",23592,40,1.13 [0.79-1.59],0.5062654839530369
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27217,1307,1.10 [1.04-1.17],0.0021969262545848
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,23678,126,1.15 [0.95-1.40],0.1487027657478996
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,23713,161,1.11 [0.94-1.32],0.2250476053530566
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",23939,387,1.11 [0.99-1.24],0.0754197488638294
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,23611,59,1.18 [0.89-1.56],0.2425783364822365
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,27377,101,1.11 [0.89-1.38],0.3509140207684277
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,23850,298,1.14 [1.00-1.29],0.048399312090993
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,23852,300,1.12 [0.99-1.28],0.0704780716277848
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,25245,58,1.24 [0.94-1.64],0.1288745346577769
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,26961,3409,1.13 [1.09-1.17],1.5564786887550314e-10
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,25948,38,1.02 [0.71-1.47],0.9027380338452068
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,25969,59,1.24 [0.94-1.64],0.1250305638657033
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27464,1923,0.98 [0.93-1.03],0.346744717121088
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27468,1920,0.98 [0.93-1.03],0.36067934656203
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,25947,37,1.60 [1.15-2.23],0.0051929941144576
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27321,1238,1.06 [1.00-1.13],0.0691887702029027
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",24441,889,1.11 [1.03-1.19],0.0058286261791268
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,27636,136,1.03 [0.85-1.24],0.7811542749432795
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,27370,35,0.96 [0.65-1.42],0.8470543213843531
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,26169,86,1.09 [0.86-1.38],0.4937043669103479
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,26201,118,1.15 [0.94-1.41],0.1628787011528366
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",23683,131,1.42 [1.18-1.70],0.0001667228528521
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25868,119,1.03 [0.84-1.26],0.7960008226667825
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1685,69,0.99 [0.75-1.30],0.9377386008644556
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1794,193,0.98 [0.83-1.15],0.7947298649300141
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,25789,40,0.79 [0.56-1.12],0.1893359106040028
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1653,37,1.13 [0.79-1.62],0.5083471567851456
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27226,1477,1.08 [1.02-1.14],0.0110536285485905
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,27405,70,0.90 [0.68-1.19],0.474645945395813
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,25461,274,1.04 [0.91-1.19],0.6056184052169393
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,23960,408,1.15 [1.03-1.28],0.012584457883674
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27558,177,0.97 [0.82-1.15],0.7185269780012191
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),26922,55,0.98 [0.72-1.34],0.9153189574000636
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Angina pectoris,26371,785,1.03 [0.95-1.12],0.4183162532792516
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Aortic aneurysm,26968,101,1.04 [0.83-1.29],0.7593842096956678
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,26898,31,1.41 [0.99-2.00],0.0550832819902218
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",26971,104,1.18 [0.96-1.46],0.1208433638017827
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,19733,930,1.02 [0.94-1.09],0.6789533157419796
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,AV-block,25188,180,0.99 [0.83-1.17],0.8811014282390496
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27615,257,0.88 [0.76-1.01],0.0780657164855443
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Cardiac arrest,18921,118,1.15 [0.94-1.40],0.1799295307540696
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25145,137,1.02 [0.84-1.24],0.8095512689076658
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",25090,82,0.99 [0.77-1.28],0.9651685282035236
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,27648,20,0.91 [0.54-1.54],0.7371163500794745
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Conduction disorders,25532,524,1.00 [0.90-1.10],0.9271782548421976
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26931,1355,1.14 [1.07-1.20],2.8265756234047725e-05
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,25705,5998,1.08 [1.05-1.11],2.349188931232956e-07
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26488,186,1.00 [0.85-1.18],0.9799590078153428
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Endocarditis,25049,41,0.96 [0.67-1.37],0.8153035891568462
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27530,505,1.05 [0.95-1.16],0.3183241710037572
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypertension,26277,4884,1.09 [1.05-1.12],3.917725000266102e-07
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, essential",26293,4900,1.09 [1.05-1.12],3.217476751383662e-07
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27481,56,0.86 [0.63-1.18],0.3466650704578108
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",21481,88,0.95 [0.75-1.22],0.7095953803924666
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21455,62,1.09 [0.83-1.45],0.534299311914647
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypotension,27543,689,1.04 [0.96-1.13],0.3498579653474227
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,27122,65,1.10 [0.84-1.45],0.4796025732886967
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27086,1500,1.12 [1.06-1.19],8.18282105813099e-05
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27420,304,1.11 [0.98-1.26],0.1139862670836469
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Left bundle-branch block,25197,189,1.10 [0.93-1.29],0.2593508067344996
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27393,596,1.06 [0.97-1.16],0.1972245608223284
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26072,486,1.09 [0.98-1.20],0.1065857416503552
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27593,116,1.05 [0.86-1.30],0.6253501681776885
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",27633,206,0.99 [0.84-1.16],0.866024775395852
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Oesophageal varices,26343,41,0.71 [0.48-1.04],0.0779137998467489
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other aneurysm,26916,49,0.82 [0.58-1.15],0.2413939614290937
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other arrhythmias,25248,240,1.01 [0.88-1.17],0.8476733460087784
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,26931,64,1.30 [1.01-1.67],0.0395668475958193
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27003,136,0.90 [0.74-1.10],0.2984403725848853
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,25137,129,0.92 [0.75-1.13],0.4527401799848338
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other disorders of veins,26376,74,0.91 [0.70-1.19],0.5056136424855999
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,26349,47,1.22 [0.89-1.67],0.2088946257458919
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,26869,34,0.80 [0.53-1.21],0.2915776609575391
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,26390,88,0.94 [0.73-1.20],0.6066140726954172
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25586,578,1.01 [0.92-1.11],0.7967019102066307
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,26899,45,0.89 [0.63-1.26],0.520762964399351
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27205,338,1.13 [1.00-1.27],0.0453439106864851
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27205,159,1.08 [0.90-1.28],0.4202921790329719
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27069,234,0.96 [0.83-1.12],0.6013103169239415
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19052,249,0.92 [0.79-1.06],0.2591575688491579
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27045,204,1.07 [0.92-1.25],0.3846727962941906
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26559,257,1.06 [0.92-1.22],0.4085229869928098
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27383,337,1.03 [0.91-1.17],0.6015069625465055
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27607,331,1.02 [0.90-1.15],0.7887135113039158
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Right bundle-branch block,25182,174,0.90 [0.75-1.08],0.248298145705659
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27201,155,1.06 [0.89-1.27],0.5220667442740022
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,26953,118,1.11 [0.91-1.36],0.3048281567743756
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27413,356,1.10 [0.98-1.23],0.1243212845061212
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27387,391,1.06 [0.95-1.19],0.2902646061582012
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,27098,54,0.90 [0.65-1.23],0.5060633080759395
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,26919,53,0.85 [0.62-1.18],0.3423670978214261
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27257,141,1.10 [0.91-1.32],0.3307627266170034
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26976,179,1.01 [0.85-1.19],0.9140758928079564
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Varicose veins,26620,318,0.89 [0.78-1.02],0.0915146426756032
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,26877,49,1.06 [0.77-1.46],0.7066742833453035
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27474,532,1.04 [0.94-1.14],0.4838115263718733
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27491,378,1.08 [0.96-1.21],0.193554680691651
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24644,1422,1.08 [1.02-1.15],0.0075471529275616
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Any mental disorder,26895,3673,1.06 [1.02-1.10],0.002566615595432
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27427,447,1.07 [0.96-1.18],0.2346985060701031
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24888,1666,1.05 [0.99-1.11],0.0902508333161387
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23317,95,1.02 [0.80-1.28],0.8995170842835957
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Smoking dependency,27111,1524,1.08 [1.02-1.14],0.0106155257359781
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24989,1767,1.08 [1.02-1.14],0.004550872209655
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Vascular dementia,27535,21,1.13 [0.70-1.81],0.623658515988754
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Alzheimer disease,27648,63,0.96 [0.72-1.28],0.7741561572769111
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Bell's palsy,25996,73,1.04 [0.80-1.35],0.7739189380689833
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26389,466,1.05 [0.95-1.17],0.3164418404989442
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Cerebral cysts,27296,206,0.98 [0.84-1.15],0.8406837484639433
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27565,225,1.05 [0.90-1.22],0.518407386246188
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,27510,23,0.77 [0.47-1.28],0.3169033744197783
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,27634,52,1.24 [0.92-1.67],0.1574168320285306
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27148,58,0.83 [0.61-1.13],0.2339457349747973
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Epilepsy,26082,257,1.06 [0.92-1.22],0.4041492126975444
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27160,1335,1.06 [1.00-1.13],0.0633914529084937
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27618,269,1.04 [0.91-1.20],0.5503026137800411
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27136,1645,0.98 [0.93-1.04],0.5253726879272202
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Generalized epilepsy,27275,50,1.08 [0.79-1.47],0.6233772530457968
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Hemiplegia,27502,162,1.00 [0.84-1.20],0.962054005580994
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Hydrocephalus,27136,46,1.51 [1.13-2.02],0.0055285641083011
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,27625,60,1.10 [0.83-1.46],0.5103632133147208
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,26000,77,0.88 [0.68-1.15],0.3588799879373225
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,26005,82,1.17 [0.92-1.48],0.2048064225725659
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Memory loss,27501,73,0.91 [0.70-1.20],0.5102067619387151
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Migraine,26252,427,1.09 [0.98-1.21],0.1189734607138829
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27555,380,1.09 [0.97-1.22],0.1419208447626984
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Motor neuron disease,20129,96,1.11 [0.89-1.40],0.3617212488015359
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27454,144,1.09 [0.91-1.31],0.3523136617834904
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27039,1116,1.06 [0.99-1.13],0.0949999085683372
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Neurological diseases,26219,3055,1.05 [1.01-1.09],0.0174295349134278
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,27560,73,1.03 [0.79-1.34],0.8514451139655503
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26311,388,1.03 [0.92-1.16],0.5725675313933755
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",27576,235,1.06 [0.91-1.22],0.4636452452614998
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23070,302,1.06 [0.93-1.21],0.3598452193119683
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27150,60,1.01 [0.75-1.35],0.9662553648936448
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27203,113,0.89 [0.71-1.11],0.2931952468544543
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,27439,90,1.05 [0.83-1.33],0.6752545105309722
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other facial nerve disorders,26013,90,1.02 [0.80-1.29],0.8903715785855814
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other headache syndromes,25883,58,1.34 [1.02-1.77],0.0351742750638998
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other neurological diseases,27528,438,1.04 [0.93-1.15],0.5098430002727468
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other sleep disorders,26399,574,1.00 [0.91-1.10],0.9941911161829272
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Parkinson's disease,27635,157,1.01 [0.84-1.21],0.951006118939304
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27154,64,1.03 [0.78-1.37],0.8424269418574236
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Restless leg syndrome,27647,45,1.03 [0.73-1.44],0.8772634315541932
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Sleep apnoea,27404,500,1.00 [0.90-1.10],0.9317354292256238
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27377,36,1.42 [1.00-2.00],0.0469860851295255
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,27634,122,1.10 [0.90-1.34],0.3533300200608237
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,25954,31,0.85 [0.56-1.30],0.4498858758748882
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,27648,64,1.00 [0.75-1.33],0.9873317111786194
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),27523,20,1.12 [0.69-1.83],0.6451708921811383
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27166,43,1.16 [0.83-1.61],0.3890254922815621
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27303,218,1.00 [0.86-1.17],0.9600592475523724
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27558,195,0.97 [0.83-1.14],0.729446025806917
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,26901,37,0.88 [0.59-1.29],0.4998860142940368
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26939,75,1.28 [1.00-1.63],0.050801828573483
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27561,30,1.26 [0.85-1.87],0.2490817754516656
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,27446,66,1.26 [0.97-1.64],0.0836313670858105
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1660,44,1.23 [0.89-1.69],0.2132031009433401
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1965,85,1.03 [0.81-1.31],0.8149875747082891
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27200,77,1.01 [0.78-1.31],0.9376325713761744
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27520,618,1.02 [0.93-1.12],0.6354213056573559
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27337,473,0.97 [0.88-1.08],0.6271314188754035
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26999,135,0.91 [0.74-1.11],0.3477664277178823
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27556,471,1.04 [0.94-1.16],0.4376438951514076
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,27635,50,0.76 [0.54-1.07],0.114818063974676
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,27484,399,1.04 [0.93-1.17],0.4504190019008224
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27604,224,1.09 [0.94-1.26],0.2607267864141326
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27585,127,0.99 [0.81-1.21],0.9212669640272884
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,26882,18,0.73 [0.41-1.30],0.2886134659138272
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,26893,29,1.04 [0.69-1.59],0.8405821895451222
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,26896,32,0.93 [0.62-1.40],0.7308886628070835
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27600,384,1.02 [0.91-1.14],0.7604810337257168
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27316,100,0.99 [0.79-1.25],0.943362305973069
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,27109,24,1.31 [0.85-2.02],0.2279229264176961
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,27454,74,1.17 [0.90-1.50],0.2404719839573396
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,27530,150,1.06 [0.89-1.28],0.5096408673976011
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,27244,159,1.06 [0.89-1.27],0.5099980695161814
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,27534,76,1.09 [0.84-1.40],0.5260349022099868
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27469,253,1.07 [0.93-1.23],0.3311237180930271
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27238,115,1.15 [0.93-1.40],0.1923392881612183
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,26929,1041,1.08 [1.01-1.16],0.0219658522605582
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,27503,123,1.09 [0.89-1.33],0.4099017061496898
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,27621,113,1.09 [0.88-1.34],0.4219091448764877
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27123,259,0.97 [0.84-1.12],0.6449935103413968
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,27416,36,0.92 [0.63-1.36],0.6859684096127858
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27620,35,0.73 [0.49-1.10],0.1340011758351193
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,26903,39,0.96 [0.66-1.38],0.81011207265589
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26978,114,1.06 [0.86-1.31],0.602788407211377
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,26971,69,0.95 [0.72-1.26],0.7220111183511877
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,27143,58,1.18 [0.89-1.57],0.2499114612007481
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",26952,50,0.98 [0.71-1.35],0.8956903507343121
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27273,57,1.12 [0.83-1.50],0.4594963096388578
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27309,93,0.91 [0.71-1.15],0.4209895073801603
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,26951,87,1.06 [0.83-1.35],0.6287814879459674
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,27024,122,1.14 [0.93-1.39],0.1935297235106811
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,26937,35,1.06 [0.72-1.54],0.7779898534142167
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,26717,829,1.03 [0.95-1.11],0.4875166425769073
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,26912,48,0.77 [0.54-1.08],0.1326949778698838
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27432,309,1.08 [0.95-1.23],0.2293486357382665
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27162,39,0.89 [0.61-1.29],0.5375580686559273
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27252,129,1.05 [0.86-1.28],0.6120736473167724
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,27453,61,0.85 [0.63-1.14],0.2756315846177045
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,27605,97,0.95 [0.75-1.20],0.6776775281093781
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27527,133,1.06 [0.87-1.28],0.5656574562491079
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,27444,52,1.15 [0.85-1.56],0.3711724311939873
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,27444,52,1.02 [0.75-1.40],0.8880279991084402
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27557,526,1.01 [0.91-1.11],0.8538667349244843
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,27357,326,1.05 [0.93-1.19],0.4455991113293611
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,27126,95,1.04 [0.82-1.31],0.7500328397263033
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,27113,82,1.16 [0.91-1.48],0.2243533466018866
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Acute pharyngitis,27359,80,0.77 [0.59-1.01],0.0568735423008587
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27514,235,0.83 [0.71-0.97],0.0161531877998434
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,27342,63,0.74 [0.55-1.01],0.0549615057817399
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,All influenza,26350,75,1.02 [0.79-1.32],0.8753830061887817
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),26348,73,1.06 [0.81-1.37],0.6824013164430973
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Allergic asthma (mode),20516,123,0.97 [0.79-1.20],0.8031345728402266
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Allergic rhinitis,27497,308,1.05 [0.92-1.19],0.4463367360815087
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21992,1738,1.05 [1.00-1.11],0.0652580679736192
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",22102,1709,1.06 [1.00-1.12],0.0398599778726066
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),27369,93,1.21 [0.97-1.51],0.0965245991455036
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",26331,56,1.31 [0.99-1.74],0.055315492962021
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Bronchiectasis,24640,185,1.10 [0.93-1.29],0.2648278115973239
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",24497,42,0.92 [0.64-1.32],0.6554301499030333
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26793,2338,1.05 [1.00-1.10],0.0354474151323254
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26178,67,1.06 [0.80-1.39],0.6881832020804473
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Chronic sinusitis,26277,166,1.25 [1.06-1.47],0.0090218386178602
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27545,718,1.05 [0.97-1.14],0.2494545674711961
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Deviated nasal septum,26241,130,1.08 [0.89-1.31],0.4330558570592778
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25747,4243,1.05 [1.02-1.09],0.0034483364600715
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26493,382,1.07 [0.96-1.20],0.2199913275355716
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Early onset COPD,27328,501,1.04 [0.94-1.15],0.4185255675528578
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Emphysema,24642,187,1.24 [1.06-1.44],0.0059811785727264
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26404,112,1.11 [0.90-1.37],0.3191432825601807
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27465,1190,1.07 [1.00-1.14],0.0476774491724495
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Interstitial lung disease,26427,135,1.11 [0.92-1.34],0.2951670100619189
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Later onset COPD,26230,217,1.08 [0.93-1.26],0.2969064783364774
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,27640,155,0.93 [0.78-1.12],0.463991520928889
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Nasal polyp,26219,108,1.13 [0.91-1.40],0.2628692613309206
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27442,605,1.12 [1.03-1.23],0.0106108479436844
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other diseases of pleura,27472,1225,1.09 [1.03-1.16],0.0057747098426309
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26997,886,1.09 [1.01-1.17],0.0235555480331923
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other pleural conditions,26281,34,0.93 [0.63-1.39],0.7316459766899375
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27594,195,1.04 [0.89-1.22],0.6073091272151707
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27566,840,1.13 [1.04-1.21],0.0022014916374617
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pleural effusion,26825,578,1.09 [1.00-1.20],0.055729463570311
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pleural plaque,26300,53,1.08 [0.79-1.46],0.640013254007977
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27263,988,1.06 [0.99-1.14],0.0885724713857182
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27621,136,0.95 [0.78-1.16],0.6168972951121118
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pneumothorax,26311,64,1.22 [0.93-1.60],0.1510524305754156
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pollen allergy,27613,265,1.04 [0.90-1.19],0.594828191521882
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pulmonary oedema,27436,37,0.88 [0.60-1.29],0.5100538700206432
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Respiratory insufficiency,20431,38,1.06 [0.74-1.53],0.7440098155541737
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27425,588,1.11 [1.01-1.21],0.0267732435749017
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26419,308,1.05 [0.93-1.20],0.4131117894093554
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Viral pneumonia,26460,185,1.08 [0.91-1.27],0.3842748444742935
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",27388,159,0.99 [0.83-1.19],0.9501237255499524
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,15979,101,1.02 [0.81-1.28],0.8891137884190015
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21176,65,1.09 [0.83-1.43],0.5449154640163455
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute appendicitis,27449,160,0.95 [0.79-1.13],0.5448797987406298
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute gastritis,22109,74,0.97 [0.74-1.26],0.8174769256757595
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute pancreatitis,26062,158,1.11 [0.93-1.32],0.2552610829830641
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute peritonitis,27216,73,1.03 [0.79-1.34],0.8257973991987891
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Alcoholic liver disease,26868,82,0.94 [0.74-1.21],0.6384901872992316
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Barrett oesophagus,22381,346,1.00 [0.88-1.13],0.9584588082164512
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",25958,54,0.85 [0.62-1.18],0.3309869409430676
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27240,54,0.85 [0.62-1.17],0.3268538336139497
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Cholecystitis,26081,177,0.97 [0.82-1.15],0.741797059674586
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Cholelithiasis,26812,908,1.01 [0.94-1.09],0.7379729011298009
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Chronic gastritis,22289,254,1.06 [0.92-1.22],0.4078449031014036
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Chronic pancreatitis,25947,43,0.93 [0.66-1.32],0.6842797032749959
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27502,77,0.77 [0.59-1.01],0.0583656778569257
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Coeliac disease,26237,117,0.99 [0.81-1.23],0.9606337676463416
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Collagenous colitis,26082,57,1.12 [0.83-1.49],0.4605916444572759
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27465,208,1.06 [0.91-1.23],0.4852914036508344
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Constipation,27428,1171,1.04 [0.97-1.11],0.2788066959544001
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Crohn disease,26121,96,1.08 [0.86-1.35],0.5274105430612759
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27302,67,0.95 [0.72-1.26],0.7179016462720388
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26118,93,1.11 [0.88-1.40],0.3674022133260457
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Dental caries,26813,258,1.11 [0.97-1.27],0.1321482887902629
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,25587,1828,1.02 [0.96-1.07],0.5219213091379005
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of appendix,27490,201,1.02 [0.87-1.20],0.7764610910001042
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of liver,27531,745,1.02 [0.94-1.11],0.6448869450608037
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",25931,3896,1.01 [0.97-1.05],0.5744777057630481
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27158,603,1.09 [1.00-1.20],0.0533339116409039
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27566,423,1.11 [1.00-1.24],0.0516525653182276
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26681,126,1.08 [0.88-1.31],0.4653767019796064
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26522,71,1.06 [0.81-1.38],0.6764034627978976
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27374,1254,1.04 [0.98-1.11],0.1954554048991974
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of tongue,26536,123,0.92 [0.75-1.13],0.4319969416003552
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27136,1232,1.02 [0.95-1.09],0.584690037862226
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,23550,2439,1.04 [0.99-1.09],0.0840837131683577
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Duodenal ulcer,22180,145,1.03 [0.85-1.24],0.7713516442306636
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27579,114,1.01 [0.82-1.25],0.9338459390998036
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27508,80,1.06 [0.82-1.36],0.6626246188059963
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,26884,98,0.83 [0.66-1.06],0.1307573768713033
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21291,180,1.03 [0.87-1.22],0.7184218855961166
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Functional dyspepsia,22553,518,1.03 [0.93-1.13],0.5882261360845892
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastric ulcer,22312,277,0.99 [0.86-1.14],0.9001167171563926
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,24278,2243,1.05 [1.00-1.10],0.0639583588715206
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22439,404,0.99 [0.88-1.11],0.8349006682195985
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,22586,8076,1.03 [1.00-1.05],0.0494372737167031
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,GI-bleeding,27132,1012,1.03 [0.96-1.10],0.4263670910094462
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,26615,60,1.09 [0.82-1.46],0.5471690171957981
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,22037,1290,1.07 [1.01-1.14],0.0304882498074082
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",26841,55,1.05 [0.78-1.42],0.7494143321577935
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Hernia,26494,2735,1.01 [0.97-1.05],0.6832340379274058
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Impacted teeth,27517,74,1.15 [0.89-1.49],0.2780264828780198
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Impaction of intestines,21145,34,1.67 [1.20-2.33],0.002427703129194
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Inguinal hernia,24429,670,0.98 [0.90-1.07],0.631824326405316
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",23838,79,1.12 [0.87-1.43],0.396550534317559
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,21185,74,0.94 [0.72-1.23],0.6629627198238885
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26256,136,1.07 [0.88-1.29],0.5135142531046604
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,21682,571,1.04 [0.94-1.14],0.4686294764621845
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,27623,391,1.07 [0.96-1.20],0.2109891860414388
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26721,696,1.01 [0.93-1.10],0.8076597006031214
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26908,883,1.04 [0.96-1.12],0.3215789171849223
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22187,152,1.14 [0.95-1.36],0.1536291243903665
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oesophagitis,22525,490,1.04 [0.94-1.15],0.5000361527718584
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27604,132,1.00 [0.82-1.22],0.9770617989351328
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23804,45,1.23 [0.89-1.70],0.214639308793186
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22409,1298,1.05 [0.98-1.11],0.1452762983939937
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26101,197,0.99 [0.84-1.17],0.9181603808526716
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,26066,162,0.99 [0.83-1.18],0.9119366869944316
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of intestine,22626,1515,1.02 [0.96-1.08],0.4743693356756907
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of intestines,26008,4897,1.03 [1.00-1.07],0.0564496523450887
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26526,194,1.01 [0.86-1.19],0.927663014141218
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of liver,27389,603,1.02 [0.93-1.12],0.6780745980698527
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,22568,533,1.03 [0.93-1.13],0.6069220039336849
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of pancreas,25984,80,1.00 [0.78-1.29],0.996633896165158
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27509,366,1.14 [1.01-1.27],0.0300653162303309
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22808,773,0.97 [0.90-1.06],0.5447192564568244
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27144,1024,1.03 [0.96-1.11],0.391114595399516
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26735,180,1.21 [1.03-1.42],0.0187084138334089
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,22324,1213,1.04 [0.97-1.11],0.2706575678044697
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),23831,1796,1.00 [0.95-1.05],0.9832611939226166
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,26865,79,0.76 [0.58-1.00],0.0476048131139222
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26796,771,1.00 [0.92-1.09],0.9860346571293988
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21340,229,1.23 [1.06-1.41],0.0050154568896121
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27493,94,1.08 [0.85-1.36],0.5300884832620163
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21457,346,1.12 [1.00-1.26],0.0562204685904042
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26256,136,1.17 [0.97-1.41],0.1005282349907289
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Recurring oral aphthae,27638,58,0.99 [0.74-1.34],0.9586255502233684
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26571,124,1.02 [0.84-1.25],0.8179373133625449
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Toxic colitis,26057,32,0.74 [0.48-1.14],0.1700340611698028
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22219,184,1.21 [1.04-1.42],0.0169285960074544
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ulcerative colitis,26169,144,1.31 [1.10-1.56],0.0024109334629906
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26151,126,1.37 [1.14-1.64],0.0009168545786393
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Umbilical hernia,24038,279,0.93 [0.81-1.07],0.3180035508920553
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,21214,103,1.13 [0.91-1.40],0.2723508256161914
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ventral hernia,23981,222,1.03 [0.88-1.19],0.7466349712270105
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Volvulus,21175,64,1.09 [0.82-1.44],0.554687457179267
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27593,159,1.02 [0.85-1.22],0.8622257394283309
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,27374,76,1.02 [0.79-1.32],0.8783979930176116
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26163,149,1.08 [0.90-1.30],0.3944715078215314
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27021,545,1.05 [0.96-1.16],0.2812053080676674
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26673,197,1.06 [0.91-1.25],0.4361699830722227
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,26185,171,1.20 [1.02-1.42],0.0291155146974719
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,27385,226,1.09 [0.94-1.26],0.2655698996446237
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27550,391,1.06 [0.94-1.18],0.3307769140580835
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27206,47,1.10 [0.80-1.52],0.5440908673649174
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26180,2582,1.06 [1.02-1.11],0.0073438834126706
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27188,443,1.05 [0.94-1.16],0.4112958090363848
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27062,317,1.05 [0.92-1.19],0.491943640489295
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27261,785,1.08 [1.00-1.17],0.0622783646776267
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",27636,46,1.17 [0.84-1.61],0.3497220874315841
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,26071,57,1.00 [0.74-1.35],0.9741569806454126
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26787,42,1.15 [0.82-1.62],0.4065862983003984
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,27379,220,1.07 [0.92-1.25],0.3541463580287306
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26305,291,1.08 [0.94-1.23],0.266656909067413
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,26047,33,1.13 [0.77-1.66],0.5353285189581773
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27564,70,1.08 [0.83-1.41],0.5626192362318032
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,26615,139,1.27 [1.06-1.52],0.0086050863003198
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27455,157,0.81 [0.67-0.98],0.0325464634939202
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27190,31,0.99 [0.66-1.48],0.9618373546190484
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,26065,51,0.86 [0.61-1.19],0.358716862985636
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27121,1107,1.07 [1.00-1.14],0.0542014217304029
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26336,322,1.14 [1.01-1.29],0.0351102809937064
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,26051,37,1.25 [0.88-1.78],0.2195652027670696
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27564,266,0.95 [0.82-1.09],0.4598370818753147
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27220,61,0.87 [0.64-1.17],0.3504218134187032
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27517,219,0.90 [0.77-1.05],0.1791927161044847
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27616,182,0.98 [0.83-1.16],0.806468121827202
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26139,125,1.14 [0.93-1.39],0.2029077042526125
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26207,193,1.04 [0.88-1.22],0.6426388210221856
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27607,173,0.97 [0.82-1.16],0.7557585769373596
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",26144,130,1.05 [0.86-1.27],0.6391774980046445
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,27614,120,1.12 [0.92-1.38],0.2520425952018541
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,24275,134,1.14 [0.94-1.38],0.181969912740722
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,25824,4659,1.03 [0.99-1.06],0.1008928419975708
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,24458,3293,1.03 [0.99-1.07],0.1917593202837311
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,24236,95,1.03 [0.82-1.30],0.8144603962624083
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,24824,153,1.18 [0.99-1.41],0.063925303813477
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,24832,161,1.17 [0.99-1.39],0.0708226003630107
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,27418,115,0.97 [0.79-1.20],0.8068446504101285
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",24717,46,0.89 [0.63-1.26],0.5145959351853622
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,21913,748,1.02 [0.94-1.11],0.6099280739063656
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27589,123,0.96 [0.78-1.19],0.7363243306912326
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24965,294,1.01 [0.89-1.16],0.8436746501034508
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,24195,6249,1.03 [1.00-1.06],0.0717021958854054
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26286,109,0.98 [0.79-1.22],0.8383040466302704
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,24253,112,0.97 [0.79-1.21],0.8169137495862309
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24753,612,1.07 [0.98-1.18],0.1251440211062167
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26765,2094,1.06 [1.01-1.11],0.0294101079409301
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24366,225,1.14 [0.98-1.32],0.0803136103194413
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,24418,277,1.17 [1.03-1.33],0.0195623327615467
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24291,150,1.15 [0.96-1.38],0.1284960773153598
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,27135,35,0.76 [0.51-1.15],0.1932270172850358
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,22481,1316,1.03 [0.97-1.10],0.2819898777192056
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21560,395,1.06 [0.95-1.19],0.3186358926675517
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27596,385,1.05 [0.94-1.18],0.3708968262712517
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21233,68,1.13 [0.87-1.48],0.3560159569041093
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21517,352,0.90 [0.80-1.02],0.1052074269420872
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24471,330,1.05 [0.93-1.19],0.4612880619501769
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,21927,762,1.05 [0.97-1.14],0.2517812734213313
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,24699,28,0.84 [0.54-1.31],0.4449117044275767
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25228,557,1.07 [0.97-1.17],0.1730560805183554
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,24957,286,1.02 [0.90-1.17],0.7329140401375781
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,21878,713,1.05 [0.97-1.14],0.2500879558060058
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,24224,83,1.30 [1.03-1.63],0.0281487333755311
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",24203,62,1.18 [0.89-1.56],0.2400562994555986
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,26230,53,1.11 [0.82-1.49],0.4980415103153544
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27314,1137,1.02 [0.96-1.09],0.5205155169737732
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26820,643,1.05 [0.96-1.15],0.2630542155310089
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27538,345,1.11 [0.98-1.25],0.0912685733045466
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,22942,1777,1.04 [0.99-1.10],0.1219462129162385
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,21246,81,1.01 [0.78-1.30],0.9538004315760112
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,24221,80,1.01 [0.78-1.30],0.9599552735924672
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,21191,26,0.89 [0.56-1.41],0.6225323761247828
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21277,112,0.93 [0.75-1.16],0.5096696716554946
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,26408,231,0.95 [0.82-1.11],0.5320556281399521
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,26415,238,1.02 [0.88-1.18],0.8012511005321084
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,27606,86,1.01 [0.79-1.29],0.9594026605975814
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26234,1563,1.09 [1.03-1.15],0.0040732336410631
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24257,116,0.87 [0.70-1.08],0.2092846549210964
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21284,119,0.75 [0.60-0.93],0.0099968968987962
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25306,635,1.03 [0.94-1.13],0.5315751256952901
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,23201,2036,1.04 [0.99-1.09],0.1433648992823647
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,27156,56,0.75 [0.54-1.03],0.078659443601604
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,27622,73,1.03 [0.79-1.35],0.808148245366163
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24223,82,1.15 [0.90-1.47],0.2596336243061087
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25236,1095,1.07 [1.00-1.14],0.0632986844934279
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,24207,66,1.13 [0.86-1.47],0.3927153915213618
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,22276,1111,1.04 [0.97-1.11],0.2894797217987285
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26277,100,0.98 [0.78-1.23],0.8697585377208106
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,24210,69,1.23 [0.95-1.60],0.1217789802905233
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,24788,117,1.13 [0.92-1.38],0.2497132217055309
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24545,404,0.99 [0.89-1.11],0.9111402392944472
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27311,211,1.07 [0.92-1.25],0.3769089315464157
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25135,464,1.10 [0.99-1.22],0.0735134058107321
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27547,326,1.11 [0.98-1.25],0.102531862001932
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27630,38,0.97 [0.67-1.40],0.8606037349391841
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24346,205,1.06 [0.91-1.25],0.4315744797707657
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22199,592,1.13 [1.03-1.24],0.0093687064396929
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24644,503,1.04 [0.94-1.15],0.4618751421574263
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24314,173,1.18 [1.00-1.39],0.0501603410134743
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",21202,37,0.77 [0.52-1.15],0.1967638541168032
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,22926,1761,1.05 [0.99-1.10],0.1050687679193891
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,21611,446,0.97 [0.87-1.08],0.5453292346179016
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27186,86,1.06 [0.83-1.35],0.6482584592541981
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",27571,51,0.84 [0.60-1.17],0.3032222267343892
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",26040,29,0.85 [0.55-1.31],0.4637647873663655
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,21239,74,1.05 [0.81-1.36],0.7209928043082583
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,24763,92,1.12 [0.89-1.41],0.341811338332468
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,21514,349,1.11 [0.98-1.24],0.0979650332671367
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24415,274,1.02 [0.89-1.17],0.7481520190450639
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,24883,212,1.15 [0.99-1.34],0.0728154780417278
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,24782,111,1.04 [0.84-1.29],0.7321604263578738
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,23444,50,1.41 [1.05-1.90],0.020526613930272
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",27633,41,0.89 [0.62-1.29],0.5436465465257408
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24750,609,1.05 [0.95-1.15],0.3363910664576165
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],27189,89,0.97 [0.76-1.24],0.8179533471083216
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26556,2415,1.05 [1.00-1.09],0.058279157721805
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24250,109,0.99 [0.80-1.23],0.9274448065164076
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25036,365,1.10 [0.98-1.23],0.1236357004192906
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26253,185,1.08 [0.91-1.27],0.3857159155802577
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,24820,149,1.04 [0.87-1.26],0.6542353123064404
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25735,1064,1.02 [0.96-1.10],0.5091053913355758
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25378,707,1.01 [0.93-1.10],0.7620208053309615
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],24186,45,1.07 [0.76-1.49],0.7126283626958556
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27242,142,0.98 [0.80-1.18],0.7967115869758598
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24299,158,0.98 [0.82-1.18],0.8455632347569628
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,24198,57,0.89 [0.65-1.21],0.4436409851391082
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),21203,38,1.04 [0.73-1.50],0.8140307103287932
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Acute renal failure,27082,846,1.10 [1.02-1.18],0.0170060368116558
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11234,76,0.94 [0.72-1.23],0.6482568201472116
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,14940,78,0.95 [0.73-1.23],0.6858155165734149
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27353,325,1.00 [0.88-1.13],0.973025626299829
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27090,62,0.65 [0.47-0.90],0.0085282794937686
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26931,695,1.04 [0.96-1.13],0.3491043660686309
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,27454,31,0.84 [0.55-1.28],0.421862062795169
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,27472,189,1.06 [0.90-1.25],0.4878614046792275
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Cystitis,25426,162,1.07 [0.89-1.27],0.4789176828241475
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Dialysis,26297,61,1.32 [1.01-1.72],0.040678625050877
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,11929,1149,1.06 [0.99-1.13],0.0951951021959093
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15067,205,0.90 [0.76-1.06],0.1970035350494261
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Endometriosis,11297,139,0.92 [0.76-1.12],0.409544532002566
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",11544,386,0.93 [0.83-1.05],0.2459874010487719
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11580,422,1.02 [0.91-1.13],0.787321623900443
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23323,4304,1.03 [1.00-1.07],0.0498890522899844
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27494,71,1.27 [0.99-1.63],0.0613313026531945
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Hydrocele,10866,86,0.99 [0.78-1.27],0.96548563280406
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,26148,224,1.10 [0.95-1.27],0.2240718357003789
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11540,760,1.09 [1.01-1.18],0.0325485136829189
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,14932,237,0.98 [0.85-1.14],0.81134267266403
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),10886,106,0.99 [0.79-1.24],0.917989282092934
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Irregular menses,14936,125,0.86 [0.70-1.06],0.1579314602164504
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11454,296,1.00 [0.87-1.14],0.9743208525486016
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25328,64,0.89 [0.66-1.19],0.4136494923230553
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12578,1420,1.01 [0.95-1.08],0.679283943020474
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,10829,49,1.05 [0.76-1.44],0.7665759751023609
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11260,102,1.15 [0.92-1.43],0.2120049715023432
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",27636,37,1.41 [1.00-1.98],0.0513930186401999
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",27643,47,1.02 [0.74-1.42],0.902068722802178
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26786,1522,1.07 [1.01-1.13],0.020092797906466
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,25738,474,1.09 [0.99-1.21],0.0818773216338582
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,14928,66,0.94 [0.70-1.24],0.644527825962649
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27598,315,1.12 [0.99-1.27],0.0685138189440371
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,10936,156,1.02 [0.85-1.22],0.8591770220160142
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,10900,120,0.93 [0.76-1.15],0.5165371566433804
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,10856,76,0.93 [0.72-1.22],0.6084914939266184
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,27611,53,1.08 [0.80-1.47],0.6182686124870511
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26366,1102,1.05 [0.98-1.13],0.1355171991388618
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,14813,118,1.04 [0.85-1.28],0.6970339721791388
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11243,85,1.03 [0.81-1.32],0.7835740842876266
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11383,225,1.00 [0.86-1.16],0.9888663761881455
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11217,59,1.15 [0.86-1.53],0.3530712360746917
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11265,107,1.12 [0.90-1.39],0.3050836408971208
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26180,256,1.09 [0.95-1.26],0.2120801756666602
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,27395,112,1.17 [0.95-1.43],0.1427204909718169
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11344,186,1.02 [0.86-1.20],0.8560818635842286
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11238,80,1.03 [0.80-1.32],0.8264749914606907
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11584,426,1.04 [0.93-1.16],0.5221643929392565
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,11227,69,1.14 [0.88-1.49],0.3167912524238637
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11542,384,1.09 [0.97-1.22],0.1338597022793133
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,27472,49,1.29 [0.96-1.74],0.0969073306865001
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",10889,109,1.17 [0.95-1.44],0.1423736576002299
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27442,1518,1.06 [1.00-1.12],0.0395452056567243
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",26063,139,1.09 [0.91-1.32],0.3483741973337696
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26314,78,0.80 [0.61-1.05],0.101964971533134
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27099,71,1.04 [0.80-1.36],0.7562484057364625
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Urethral stricture,25437,173,1.14 [0.97-1.35],0.1194082942174463
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27417,389,0.95 [0.84-1.07],0.3734905617267943
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11259,101,1.18 [0.95-1.46],0.14204634875855
